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We recently reported that the first detectable expression of SMC-specific proteins during coronary smooth muscle cell (CoSMC)
differentiation from isolated proepicardial cells was restricted to cells undergoing epithelial-to-mesenchymal transformation
(EMT). The objectives of this study were to examine more closely the relation between actin cytoskeletal rearrangements and
serum response factor (SRF)-dependent transcription, and to specifically test whether rhoA–GTPase signaling is required for
CoSMC differentiation. We report here that PDGF-BB stimulates EMT and promotes SRF-dependent expression of SMC marker
genes calponin, SM22a, and SMgactin (SMgA) in proepicardial cells. C3 exoenzyme or rhoGDI, inhibitors of rhoA signaling,
blocked PDGF-BB-induced EMT, prevented actin reorganization into stress fibers, and inhibited CoSMC differentiation.
Incubation with the selective p160 rho-kinase (p160RhoK) inhibitor Y27632 (RKI) blocked EMT, prevented the appearance of
calponin and SMgA-positive cells, and abolished expression and nuclear localization of SRF. To test the role of RhoK signaling
for CoSMC differentiation in vivo, quail proepicardial organs (PEOs) were pretreated with RKI or vehicle and then grafted into
age-matched host chick embryos to produce a chimeric epicardium. The ability of grafted cells to participate in coronary vessel
formation was monitored by staining with antibodies for quail cell nuclear antigen and SMC marker proteins. Proepicardial cells
pretreated with RKI failed to form CoSMCs in vivo. Time course studies traced this deficiency to a failure of epicardial-derived
mesenchymal cells to migrate into or survive within the myocardium. In summary, these data point to important roles for
rhoA–RhoK signaling in molecular pathways controlling cytoskeletal reorganization, SRF-dependent transcription, and cell
survival that are required to produce CoSMCs from proepicardial cells. © 2001 Elsevier Science
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We recently reported that the first detectable expression
of calponin, SM22a, and smooth muscle g-actin (SMgA)
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(713) 798-8920. E-mail: mmajesky@bcm.tmc.edu.404during coronary smooth muscle cell (CoSMC) differentia-
tion from proepicardial cells was found in cells that had
initiated reorganization of the actin cytoskeleton from
subcortical bundles to elongated stress fibers characteristic
of epithelial-to-mesenchymal transformation (EMT) (Land-
erholm et al., 1999). Remodeling of actin filaments into
stress fibers is thought to depend on signaling pathways
mediated by members of the rhoGTPase family (for review,
see Hall, 1998). Rho, rac, and cdc42 GTPases regulate many
actin-based cytoskeletal processes including cell adhesion,
migration, phagocytosis, cell survival, and contractility
(Kaibuchi et al., 1999). Moreover, stimulation of serum
response factor (SRF)-dependent transcription of a c-fos
promoter in NIH-3T3 cells, a skeletal a-actin promoter in
neonatal rat cardiac myocytes, and a smooth muscle a-actin0012-1606/01 $35.00
© 2001 Elsevier Science
All rights reserved.
405Coronary Smooth Muscle DifferentiationFIG. 1. PDGF-BB stimulates epithelial to mesenchymal transformation (EMT) and CoSMC differentiation. HH stage 17 quail proepicardial cells
were incubated for 60 h in the absence (A, C, E, G) or presence (B, D, F, H) of PDGF-BB (20 ng/ml), fixed, and then stained with Coomassie blue
(A, B), AlexaFlour 488-phalloidin and DAPI (C, D), anti-calponin (E, F), or anti-SMgA (G, H). Note that PDGF-BB produced cytoskeletal actin
rearrangements characteristic of EMT and greatly increased the frequency of cells immunopositive for SMC markers calponin and SMgA.© 2001 Elsevier Science. All rights reserved.
406 Lu et al.promoter in adult rat aortic SMCs was reported following
upregulation of rhoA-mediated signaling (Hill et al., 1995;
Wei et al., 2001; Mack et al., 2001). In addition, transcrip-
tion of a subset of SRF-dependent target genes in fibroblasts
is controlled by actin treadmilling, possibly via changes in
G-actin levels (Sotiropoulos et al., 1999). Taken together
with the above findings, the close association that we
observed between cytoskeletal actin remodeling and the
onset of SRF-dependent transcription of SMC marker genes
in proepicardial cells (Landerholm et al., 1999) suggests that
activation of rhoA-dependent pathways by extracellular
signals may be a critical step for formation of CoSMCs from
epicardial progenitors.
In the early embryo, diffusible factors released by endo-
thelial cells (ECs) are thought to act on nearby mesenchy-
FIG. 2. PDGF-BB, but not PDGF-AA or PDGF-AB, stimulates
epithelial to mesenchymal transformation (EMT) of proepicardial
cells. (A) The percentage of total surface area of individual proepi-
cardial colonies occupied by mesenchymal cells was determined
after treatment for 3 days with the indicated concentrations of
PDGF-AA (r), PDGF-AB (f), and PDGF-BB (). Note that PDGF-BB
stimulates EMT at a half-maximal concentration ;3 ng/ml,
whereas PDGF-AA or PDGF-AB had no effect. (B) Time course of
EMT of proepicardial cells stimulated without (F) or with 20 ng/ml
PDGFs (see symbols above) for the times indicated. The percentage
of total surface area of the proepicardial colony occupied by
mesenchymal cells is indicated. Values shown represent means 6
SEM of at least five independent experiments.© 2001 Elsevier Science. Amal cells to stimulate vascular SMC differentiation
(Owens, 1995; Folkman and D’Amore, 1996; Carmeliet,
2000). One critical parameter closely associated with the
onset of vascular SMC-specific gene transcription in devel-
oping blood vessels is directional blood flow. Therefore,
EC-derived factors important for recruitment and differen-
tiation of vascular SMCs are thought to exhibit flow-
dependent upregulation in vivo. One such factor is platelet-
derived growth factor B-chain (PDGF-B). ECs make
PDGF-BB (DiCorleto and Bowen-Pope, 1983; Collins et al.,
1985) and release it via the abluminal surface (Zerwes and
Risau, 1987). Endothelial production of PDGF-BB is en-
hanced by flow-dependent activation of a shear–stress re-
sponse element in the 59 regulatory region of the PDGF-B
gene (Hsieh et al., 1991; Mitusmata et al., 1993; Resnick et
al., 1993). The PDGF-BB homodimer strongly stimulates
SMC chemotaxis and migration (Grotendorst et al., 1982;
Ferns et al., 1991). In developing vessels, ECs recruit PDGF
b-receptor (PDGF-Rb)-expressing cells from local mesen-
chyme (Crosby et al., 1998; Hellstrom et al., 1999). In
addition, PDGF-BB can direct flk11/PECAM2 embryonic
stem cells to adopt an SMC phenotype (Yamashita et al.,
2000). Moreover, a deficiency in PDGF-B signaling results
in loss of microvascular SMCs (pericytes), numerous mi-
croaneurysms (Lindahl et al., 1997), and reduced mesenchy-
mal cell recruitment into large artery walls (Crosby et al.,
FIG. 3. Dominant negative SRF (dnSRF) inhibits PDGF-BB-
stimulated smooth muscle differentiation. Freshly explanted
HH17 quail PEOs were transfected with the indicated wild-type or
dnSRF construct cloned upstream of a lacZ reporter gene and 24 h
later were treated with PDGF-BB (20 ng/ml) or vehicle for an
additional 36 h. Cultures were then fixed and stained by double
immunofluorescence for calponin and b-galactosidase. Values in-
dicate the percentage of b-gal-positive cells that were also calponin-
positive. pEmpty control vector contains CMV, IRES, and lacZ
sequences but no insert cloned upstream of IRES. Note that
PDGF-BB increased the percentage of double-positive cells to
;100% and that both forms of dnSRF inhibited the appearance of
calponin-positive cells. * indicates significant differences relative
to wild-type SRF (pSRF-wt) (P , 0.001). Results shown represent
the means 6 SD for three independent experiments. Statistical
evaluations were made based on comparisons between pSRF-wt
and dnSRF constructs by Student’s t-test.ll rights reserved.
407Coronary Smooth Muscle Differentiation1998) and coronary vessels (Hellstrom et al., 1999). Al-
though it is clear that additional signals are required for
vessel wall assembly (Dumont et al., 1993; Sato et al., 1995;
Suri et al., 1996; Dickson et al., 1995; Li et al., 1999),
PDGF-BB is likely to play an important role in the recruit-
ment and expansion of SMCs and pericytes required for
normal vascular wall development (Hellstrom et al., 1999;
Hirschi et al., 1999).
In studies reported here, we examine the effects of
PDGF-BB and rhoA-dependent signaling on cytoskeletal
reorganization and CoSMC differentiation from proepicar-
dial cells. We also test the role of p160 rho-kinase
(p160RhoK), an important downstream effector of rhoA, in
SRF-dependent transcriptional activation of SMC marker
genes both ex vivo and in the sequence of steps from
epicardium formation to coronary wall development in
chimeric embryos in vivo. Our results suggest that rhoA/
p160RhoK-mediated signaling plays essential roles in cy-
toskeletal remodeling, SRF-dependent transcription, and
cell survival pathways required to produce CoSMCs from
progenitors in the proepicardial organ.
MATERIALS AND METHODS
Isolation and Primary Culture of Proepicardial
Cells
Fertilized Japanese quail (Coturnix coturnix japonica) eggs were
purchased from GQF Manufacturing (Savannah, GA). Fertilized
chicken eggs (Gallus gallus) were obtained from Ideal Poultry
(Cameron, TX). Embryos were staged (Hamburger and Hamilton,
1951) and proepicardial organs (PEOs) were microdissected as
described (Landerholm et al., 1999). For ex vivo culture, stage
HH17 PEOs were placed into prewarmed M199 medium supple-
mented with 30 mM glucose, 5 mM glutamine, 1.25 mM pu-
trescine, 23 antibiotic-antimycotic solution (Gibco-BRL, Gaithers-
burg, MD), and 10% fetal bovine serum in 24-well Primaria-coated
plates (Becton-Dickinson, Lincoln Park, NJ) incubated at 37°C in
95% air/5% CO2.
Immunofluorescence
For PEO cultures, cells were fixed in 4% paraformaldehyde (PFA)
and permeabilized with methanol:acetone (1:1). Nonspecific bind-
ing was blocked with normal goat serum (NGS, 1:50) in PBS and
primary antibody (1:200) was applied overnight at 4°C. After
extensive washing with 0.1% bovine serum albumin in PBS (BSA–
PBS), fluorescent secondary antibodies (1:400) in BSA–PBS were
incubated for 1 h at room temperature and again washed exten-
sively. Cultures were coverslipped and photographed using a Nikon
Optiphot 2 microscope equipped for epifluorescence. For paraffin-
embedded embryos and heart tissues, 6 mm sections were dewaxed
and rehydrated through xylene, ethanol, and PBS solutions. Non-
specific binding was blocked with 5% milk and 10% NGS–PBS,
followed by incubation with primary and secondary antibodies as
described above. All sections and cultured cells were counter-
stained with Hoechst 33342 (Molecular Probes, Eugene, OR) to
identify nuclei.© 2001 Elsevier Science. ART-PCR Analysis
RNA was prepared from single, freshly dissected PEOs or cultures
derived from single PEOs as described (Landerholm et al., 1999).
Briefly, PEOs were lysed in 200 ml guanidinium isothiocyanate-
containing solution D (Chomczynski and Sacchi, 1987), and RNA was
extracted with phenol–chloroform and precipitated with isopropanol
using 20 mg of oyster glycogen (Calbiochem, La Jolla, CA) as a carrier.
Following resuspension in 20 ml of DEPC-treated water, digestion
with DNase (1 unit/tube, 30 min, 37°C), extraction with phenol–
chloroform, and ethanol precipitation, the pellets were resuspended in
TE (10 mM Tris–HCl/1 mM EDTA, pH 7.4) and cDNA was synthe-
sized using oligo d(T) primers and reverse transcriptase (Perkin–Elmer,
Norwalk, CT). PCR amplification was carried out using the following
specific primers and cycle numbers: calponin-upstream (CTGG-
CACAGAAATACGACCC), downstream (CTGCTGCTTCTCTG-
CGTACT) (30 cycles); SM22a-upstream (CCAGTCCAAGATCG-
AGAAGA), downstream (CTTGTTGGTCCCCATCTGTA) (25
cycles); SMgActin-upstream (CAGATGTGGATCAGCAAAC-
CCGA), downstream (AAGGCTTTATTGCGCAGTGGG) (25
cycles); SRF-upstream (AACGGGACAGTGCTGAAGAC), down-
stream (GGCCTCTCAGTCACTCTTGG) (30 cycles); GAPDH-
upstream (ACGCCATCACTATCTTCCAG), downstream (CAGC-
CTTCACTACCCTCTTG) (30 cycles). DNA products were separated
on 1.5% agarose gels and stained with 0.5 mg/ml ethidium bromide,
and the band intensity was determined by Appligene Imager (Oncor,
Gaithersburg, MD). The identity of each RT-PCR product was con-
firmed by DNA sequencing. Control reactions in which reverse tran-
scriptase was omitted or the sample was preincubated with RNase (10
units, 30 min, 37°C) resulted in no detectable amplified products.
Transfection of dnSRF and Analysis of SM
Differentiation
Analysis of the effects of dominant-negative SRF (dnSRF) was
carried out as described (Landerholm et al., 1999). Stage HH17 quail
PEOs were explanted and 8 h later were transfected with wild-type
or dnSRF subcloned into IRES vectors to allow coexpression of a
b-galactosidase reporter gene. After 5 h, the transfection media was
removed and replaced with standard growth media for an additional
11 h to allow for cell recovery. At 24 h after explanting, growth
media was changed to media containing PDGF-BB (20 ng/ml) or
vehicle and maintained for an additional 36 h, after which time
colonies were fixed and stained for calponin and b-galactosidase by
double immunofluorescence (Landerholm et al., 1999).
Assay for Mesenchymal Transformation
Mesenchymal transformation was measured by determining the
percentage of total surface area of the proepicardial colony that was
occupied by mesenchymal cells (Fig. 1B). PEO colonies were
washed two times with PBS, fixed (4% PFA, 60 min), and stained
(0.005% Coomassie brilliant blue, 50% methanol, 10% acetic
acid). The mesenchymal area (mm2) was determined by measuring
diameters (average of three measurements made along three differ-
ent diagonal bisectors), first of the whole colony and then of the
central epithelial core under a dissection microscope using an
eyepiece reticle. The area of epithelial core was subtracted from the
total colony area to give the mesenchymal area. The percentage of
total colony composed of mesenchymal cells was then determined
by (mesenchymal area/total area) 3 100.ll rights reserved.
408 Lu et al.FIG. 4. Inhibition of rhoA and p160RhoK blocks EMT and CoSMC differentiation. (A) Proepicardial cells were treated with PDGF-BB (20
ng/ml) in the presence and absence of C3 exoenzyme (10 mg/ml) for 60 h, then fixed and immunostained for calponin. Note that almost no
calponin-positive cells were found when proepicardial cells were treated with C3 exoenzyme. (B) Immunoblot: Lysates of freshly isolated
proepicardial organs (D0-PEO) and proepicardial cells cultured for 5 days (D5-PEO) were analyzed by immunoblotting using anti-p160RhoK
antiserum directed to the coiled-coil domain (1:5000). A single specific immunoreactive band was obtained. The results shown are
representative of three independent experiments. Preimmune rabbit serum tested on D0-PEO. (C) Confocal immunofluoresence staining:
Proepicardial cells cultured for 60 h in the presence and absence of the p160RhoK inhibitor Y27632 (RKI, 10 mg/ml) were immunostained
for p160RhoK (1:200) (A, C) or DAPI nuclear stain (B, D). Merged images are shown in left panels. Note that p160RhoK is localized to
lamellipodial extensions and to the nucleus in cells undergoing EMT. By contrast, in RKI-treated cells, the nuclear and peripheral
membrane staining pattern was replaced by a cytoplasmic distribution. Localization of rhoA (inset) overlaps that of p160RhoK in
lamellipodia of epicardial cells undergoing EMT.
409Coronary Smooth Muscle DifferentiationWestern Blot Analysis
Cells were washed in cold PBS and extracted in SDS sample
buffer (62.5 mM Tris–HCl, pH 6.8, 10% glycerol, 2% SDS, 5% v/v
b-mercaptoethanol, 0.05% v/v 25 mg/ml bromphenol blue).
Samples were boiled for 5 min, separated on 6 or 12% polyacryl-
amide gels (30 mA) as indicated, and electrotransferred onto PVDF
membranes (Millipore, Bedford, MA). After washing with TPBS
(0.05% Tween 20 in PBS), membranes were incubated in blocking
solution (5% nonfat dry milk in TPBS) for 1 h at room temperature
and then probed with 1:5000 dilution of rabbit anti-bovine
p160RhoK polyclonal antibody (provided by Dr. Kozo Kaibuchi,
Nara Institute of Science and Technology, Japan) or preimmune
rabbit serum for 1 h at room temperature. The phosphospecific
antibodies to vimentin used were antibody TM71 (Ser71, 1:1000),
antibody YT33 (Ser33, 1:500), and antibody MO82 (Ser-82, 1:5000)
as described (Inagaki et al., 1996). Blots were washed twice in TPBS
and incubated with anti-rabbit secondary antibody conjugated with
horseradish peroxidase, and immunoreactivity was detected with
SuperSignal West Pico Chemiluminescence substrate reagents
(Pierce, Rockford, IL) according to the manufacturer’s instructions.
Preparation and Analysis of Chick–Quail Chimeras
Chick–quail chimeras were made by grafting single HH17 quail
PEOs into the pericardial cavity of host chick embryos of the same
developmental stage (Gittenberger-de Groot et al., 1998). Quail
PEOs were excised with tungsten needles, placed in M199 medium
supplemented as described above, incubated at room temperature
for 12–24 h in the absence or presence of 10 mM Y27632 with
end-over-end rotation, and then thoroughly washed twice in sterile
Tyrode solution. Recipient HH17 chicken eggs were opened, the
vitelline membrane was excised locally, and the quail PEO was
grafted between the host heart and native chick proepicardium. In
some experiments, outgrowth of the host chick PEO was blocked
by insertion of a piece of egg shell membrane prior to grafting of the
donor quail PEO as described (Manner, 1999). Quail–chick chime-
ras were incubated at 37°C for an additional 2–10 days. For
detection of quail cells, chimeric hearts were dissected and fixed
overnight in a solution of 2% acetic acid in 100% ethanol,
embedded in paraffin, and serially sectioned in the coronal plane at
6 mm. Five nonconsecutive sections encompassing 540 mm of the
median portion of the heart, which included the AV groove and
equal portions of flanking atrial and ventricular tissues, were
systematically selected for immunofluorescence analysis. Staining
was performed with QCPN antibody and anti-SMaactin and the
total number of immunopositive cells in the 540 mm area was
determined.
Materials
PDGFs (human recombinant) were from R&D Systems (Minne-
apolis, MN). Polyclonal anti-SRF was provided by Dr. Ron Prywes
(Columbia University). Polyclonal antibodies to p160RhoK were
from Dr. Kozo Kaibuchi (Nara Institute of Science and Technology,
Nara, Japan). Other antibodies were purchased from the indicated
suppliers: anti-SMaactin (clone 1A4), anti-avian calponin (C6047),
anti-human vinculin (hVIN-1) were from Sigma (St. Louis, MO);
anti-SMgactin (clone B4; ICN, Costa Mesa, CA); anti-rhoA (Cy-
toskeleton, Denver, CO); anti-b-galactosidase (Boehringer Mann-
heim, Indianapolis, IN); anti-cytokeratin (Z622; Dako, Carpinteria,
CA). Y27632 was a gift from Yoshitomi Pharmaceutical Industries,
Ltd. (Saitama, Japan). The QCPN monoclonal antibody was from© 2001 Elsevier Science. Athe Developmental Studies Hybridoma maintained by the Depart-
ment of Biological Sciences of The University of Iowa (IA City).
Fluorescent-labeled secondary antibodies and AlexaFluor 488–
phalloidin conjugate were from Molecular Probes (Eugene, OR).
Preimmune rabbit serum was from Chemicon (Temecula, CA).
Wortmannin, AACOCF3, and 8-bromo-cyclicAMP were from
Sigma. Botulinium C3 exotoxin and SB203580 were from Calbio-
chem. ML-9 and PD98059 were from BioMol Research Laboratories
(Plymouth Meeting, PA).
RESULTS
PDGF-BB Stimulates Mesenchymal Transformation
and CoSMC Differentiation from Proepicardial
Cells
Explanted PEOs from HH17 quail embryos produced an
epicardial cell outgrowth during the first 48 h that was
characterized by extensive cell–cell contacts, subcortical
actin bundles, and an epithelial pattern of organization
(Figs. 1A and 1C) (Landerholm et al., 1999). Addition of
PDGF-BB (20 ng/ml, 48 h) at the time of explant stimulated
EMT as assessed by loss of cell–cell contacts, rearrange-
ment of cytoplasmic actin into stress fibers, and acquisition
of a motile phenotype (Figs. 1B and 1D). Coordinate with
stimulation of EMT, we observed that PDGF-BB produced a
marked increase in the number of proepicardial cells ex-
pressing markers of CoSMC differentiation, including cal-
ponin (Figs. 1E and 1F), SMgactin (Figs. 1G and 1H), and
SM22a (not shown), by immunofluorescence. PDGF-BB
produced half-maximal EMT at 3 ng/ml, whereas PDGF-AA
or PDGF-AB had no effect (Fig. 2A). By 3 days in PDGF-BB-
containing medium essentially all proepicardial cells had
completed EMT. By contrast, only ;35% of proepicardial
cells in untreated, PDGF-AA-treated, or PDGF-AB-treated
cultures exhibited a mesenchymal phenotype after 3 days
(Fig. 2B). These results indicated that PDGF-BB stimulates
proepicardial cells to undergo EMT and express proteins
characteristic of CoSMC differentiation.
PDGF-BB-Induced CoSMC Differentiation Requires
Transcriptionally Active SRF
RT-PCR analysis indicated that PDGF-BB (10 ng/ml,
48 h) upregulated SRF mRNA levels three- to fourfold when
added to freshly explanted PEOs (not shown). To determine
whether SRF activity is required for PDGF-BB-induced
CoSMC differentiation, we employed two different forms of
dominant-negative SRF (dnSRF). pSRF-pm1 has point mu-
tations within the MADS box, which disables binding to
DNA (Johansen and Prywes, 1995), whereas pSRF-D5 is a
naturally occurring splice variant (Belaguli et al., 1999) that
lacks the C-terminal transactivation domain encoded by
exon 5. Both forms of dnSRF as well as wild-type SRF
(wtSRF) were cloned upstream of an internal ribosome
entry sequence (IRES), thus allowing coexpression of a
b-galactosidase reporter. wtSRF or dnSRFs were transfected
into proepicardial cells and CoSMC differentiation was
determined 4 days later by immunofluorescence (Lander-ll rights reserved.
410 Lu et al.holm et al., 1999). Both forms of dnSRF, but not wtSRF or
pEmpty control vector, strongly inhibited coronary SMC
differentiation stimulated by PDGF-BB, as assessed by co-
expression of calponin and b-galactosidase (Fig. 3). These
results show that PDGF-BB-mediated SMC differentiation
requires transcriptionally active SRF.
Inhibition of the RhoA/p160RhoK Pathway Blocks
Mesenchymal Transformation
To identify pathways by which PDGF-BB stimulates
EMT and SRF-dependent CoSMC differentiation from pro-
epicardial cells, we tested the effects of inhibitors of the
rhoA/p160RhoK pathway. The rationale for targeting this
pathway is based on the following evidence: (1) formation of
CoSMCs from proepicardial cells is tightly linked with
EMT in vitro (Landerholm et al., 1999); (2) epicardial cell
EMT provides mesenchymal cell precursors for coronary
SMC in vivo (Dettman et al., 1998; Gittenberger-de Groot
et al., 1998; Wada et al., 2001); (3) rhoA mediates rearrange-
ment of cytoplasmic actin into stress fibers (Ridley and
Hall, 1992; Hall, 1998); and (4) rhoA activation has been
shown to stimulate SRF-dependent transcription (Hill et
al., 1995). Treatment of explanted PEOs with C3 exoen-
zyme, which ADP-ribosylates Asn-41 and inactivates rhoA,
completely blocked EMT and prevented the appearance of
calponin-positive cells following stimulation with
PDGF-BB (Fig. 4A). Likewise, transfection of proepicardial
TABLE 1
Treatment of Unstimulated Proepicardial Cells or PDGF-BB-
Stimulated Cells with Selective Pathway Inhibitors
Treatmenta Mesenchymal area (%)b
None 66.39 (66.83)*
PDGF-BBc 100
PDGF-BB 1 Y27632d 41.43 (64.68)*
PDGF-BB 1 PD98059d 100
PDGF-BB 1 SB203580d 100
PDGF-BB 1 Wortmannind 100
PDGF-BB 1 ML-9e 46.67 (67.97)*
PDGF-BB 1 AACOCF3d 100
a Final concentrations of inhibitors used: Y27632 (10 mg/ml),
PD98059 (10 mM), SB203580 (10 mM), wortmannin (10 nM), ML-9
(0.1 mM), and AACOCF3 (10 mM).
b Calculated as the percentage of total surface area of individual
proepicardial colonies occupied by mesenchymal cells. Measure-
ments were made after 4 days of treatment. Values shown are
means 6 SEM of at least five independent experiments per treat-
ment.
c PDGF-BB used at a final concentration of 20 ng/ml added at the
time of explant.
d Inhibitors were added at the time of explant.
e ML-9 was added 24 h after explant because of interference with
attachment of the freshly excised PEO to the surface of the culture
well.
* Significantly different from PDGF-BB treatment (P , 0.01).© 2001 Elsevier Science. Acells with CMV-rhoGDI, an inhibitor of GDP dissociation
from rhoA, at the time of explant also blocked EMT and
calponin expression (not shown).
One of the principal downstream effectors of rhoA is the
rho-binding serine–threonine kinase p160RhoK. To deter-
mine whether proepicardial cells express p160RhoK, immu-
noblot analysis was carried out on freshly dissected PEOs
(D0-PEO) and cultures derived from PEOs after 5 days of
growth in vitro (D5-PEO). Polyclonal antibodies directed
against either the coiled-coil domain (aa 421–701) or to the
rho-binding domain (aa 941–1075) of p160RhoK (Amano et
al., 1997) both recognized a single ;150-kDa band of
approximately equal intensity in D0-PEO vs D5-PEO lanes
(Fig. 4B). No other bands were detected. Confocal immuno-
fluorescence analysis using the anti-coiled-coil domain an-
tibody indicated that p160RhoK was highly concentrated in
lamellipodial extensions, co-localized with rhoA, and in the
nucleus/perinuclear region of proepicardial cells actively
undergoing EMT (Fig. 4C, panel C). By contrast, in unstimu-
lated proepicardial cells or in PDGF-BB-stimulated cells
treated with a selective rho-kinase inhibitor (RKI) Y27632
(Uehata et al., 1997), EMT was completely blocked (Table 1)
and p160RhoK was diffusely distributed in the cytoplasm
(Fig. 4C, panel A).
RKI is a novel pyridine derivative that suppresses rhoA-
and p160RhoK-induced stress fiber assembly but has no
effect on rac-induced membrane ruffling or cdc42-induced
filopodia formation (Uehata et al., 1997). It is reported to be
a highly selective inhibitor for p160RhoK with $100-fold
higher Ki for inhibition of PKC or PKA (Uehata et al., 1997).
FIG. 5. Effects of RKI on site-specific phosphorylation of vimen-
tin. Immunoblot analysis of proepicardial cell extracts from freshly
excised HH17 PEOs (D0), after 5 days of growth ex vivo in the
absence (D5) and presence (D5/RKI) of 10 mM RKI. Extracts were
separated on 12% SDS–PAGE, electrotransferred to membranes,
and then immunoblotted with phosphospecific antibodies to the
p160RhoK site at Ser-71, the PKC site at Ser-33, or the CamK-II site
at Ser-82 of vimentin. To ensure equal loading, blots were also
probed with an anti-chick vimentin monoclonal antibody H5 (VM).
Note that RKI reduces phosphorylation of vimentin at Ser-71, but
not at Ser-33 or Ser-82.ll rights reserved.
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cells in situ and to address the issue of target specificity, we
employed a panel of phosphospecific antibodies to vimen-
tin, an established substrate of p160RhoK (Sin et al., 1998)
and a target relevant to EMT in proepicardial cells. Vimen-
tin is phosphorylated at Ser-71 by p160RhoK (Inada et al.,
1999), at Ser-33 by PKC (Ogawara et al., 1995), and at Ser-82
by CaMKII (Inagaki et al., 1997). Immunoblots using phos-
phospecific antibodies to each of these sites showed that
RKI selectively inhibited phosphorylation at Ser-71, while
having no effect on endogenous phosphorylation at Ser-33
or Ser-82 of vimentin (Fig. 5). These results indicate that
under the conditions of our experiments, RKI is an effective
and selective inhibitor for p160RhoK.
Although RKI strongly suppressed EMT induced by
PDGF-BB (Table 1, Fig. 6), inhibitiors of MAPK kinase
(MEK) (PD98059), p38-MAP kinase (SB203580), PI-3-kinase
(wortmannin), or cytosolic phospholipase-A2 (AACOCF3)
had no effect on PDGF-BB-stimulated EMT (Table 1). The
myosin light chain kinase (MLCK) inhibitor ML-9 was
almost as effective as RKI for blocking PDGF-BB-mediated
EMT. While ML-9 at high concentrations can also block
PKA and PKC, we found that neither 8-bromo-cyclic AMP
(2 mM) nor phorbol ester (100 mM) had any effect on EMT in
proepicardial cells (data not shown). Neither p160RhoK nor
MLCK inhibitors had any effect on proepicardial colony
outgrowth, cell proliferation, or apoptosis rates (data not
shown). These results indicate that proepicardial cells spe-
cifically require intact signaling via rhoA and p160RhoK for
cytoskeletal rearrangements required to produce EMT.
Inhibition of p160RhoK Blocks CoSMC
Differentiation ex Vivo
Treatment of proepicardial cells with RKI at the time of
PDGF-BB addition strongly inhibited the appearance of
calponin, SM22a, and SMgactin-positive cells at the level of
both mRNA (Fig. 6A) and protein (Fig. 6B). Inhibition of
SMC marker gene expression may be secondary to complete
loss of detectable expression of SRF mRNA or protein in
RKI-treated proepicardial cells (Figs. 7A and 7B). Therefore
signaling through p160RhoK is required for PDGF-BB-
induced CoSMC differentiation from proepicardial cells ex
vivo.
Inhibition of p160RhoK Blocks Coronary Wall
Formation in Vivo
To determine whether p160RhoK is required for CoSMC
differentiation in vivo, we employed a chick–quail chi-
meric embryo approach. PEOs were obtained from HH17
quail embryos, treated with RKI or vehicle overnight,
rinsed, and grafted into the pericardial cavity of recipient
HH17 chick embryos. The host chick PEO was not removed
and therefore a chimeric epicardium was produced that was
a mixture of treated quail epicardial cells and untreated
chick epicardial cells. After 10 days of incubation, chick
embryos were dissected and chimeric hearts were recov-© 2001 Elsevier Science. Aered. Histological analysis indicated that hearts that re-
ceived quail proepicardial cells treated with saline vehicle
were indistinguishable from wild-type chick hearts and
exhibited normal subepicardial and penetrating coronary
arteries containing multiple layers of circumferentially
arranged CoSMCs (Fig. 8A, arrows). By contrast, hearts that
received a large contribution of RKI-treated quail PEOs
exhibited obvious defects in coronary wall formation.
Whereas coronary vessels were present in evidently normal
numbers and endothelial cells were apparent lining these
vessels, there were few, if any, circumferential layers of
SMCs either at the histological level (Fig. 8A) or by immu-
nofluorescence for SMaactin (Fig. 8B). Finally, QCPN stain-
ing (anti-quail cell nuclear marker) showed that vehicle-
treated quail PEO-derived cells could be detected in the
subepicardial layer, within the myocardial wall, and clus-
tered around coronary vessels of host chick hearts (Fig. 8C).
By sharp contrast, while QCPN-positive quail cells were
found in the subepicardial layer of hearts that received
RKI-treated quail PEOs, few, if any, epicardial-derived quail
cells were detected in the myocardial wall or surrounding
the coronary vessels (Fig. 8C).
To test these results by an alternate method, we prepared
a second series of chimeras in which outgrowth of the host
chick PEO was blocked by insertion of a piece of egg shell
membrane prior to grafting the donor quail PEO as de-
scribed (Manner, 1999). This method produced an epicar-
dium that is derived almost entirely from the grafted PEO.
When chimeric hearts made with RKI-treated quail PEOs
were compared to those made with vehicle-treated quail
PEOs at ED5.5 and 7.5, we observed no defects in epicar-
dium formation and no obvious defects in EMT in the AV
groove but, again, there was a dramatic reduction in the
number of QCPN-positive cells found within the host chick
myocardium (Fig. 9). This lack of QCPN-positive cells
correlated with a threefold increase in TUNEL-positive
cells in the myocardial wall at ED7.5 (RKI-treated, 25.1 6
5.7 vs vehicle-treated, 8.4 6 1.8 cells/1000 cells) with no
change in cell proliferation rates. These findings suggest
that inhibition of p160RhoK in proepicardial cells neither
prevents formation of the epicardial layer nor blocks EMT
in the AV groove. Rather, a defect is apparent in migration
of epicardial-derived mesenchymal cells into the myocar-
dium and/or survival of these cells within the myocardial
wall.
DISCUSSION
Here, we demonstrate that PDGF-BB stimulates a rhoA/
p160RhoK-dependent pathway that mediates cytoskeletal
actin reorganization and CoSMC differentiation from pro-
epicardial cells. The appearance of SMC marker-positive
cells in PDGF-BB-treated proepicardial explants was depen-
dent on transcriptionally active SRF. Analysis of chick–
quail chimeric embryos indicated that inhibition of
p160RhoK activity strongly inhibits CoSMC formation
during heart development, most likely as a result of block-ll rights reserved.
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© 2001 Elsevier Science. Aing the ability of surface epicardial cells to generate a
population of epicardial-derived mesenchymal cells (EP-
DCs) within the myocardium. EPDCs not only serve as
precursors for CoSMC (Dettman et al., 1998; Gitten-
berger-de Groot et al., 1998) but they also appear to be
required for normal development of the myocardium (Kwee
et al., 1995; Chen et al., 1998; Moore et al., 1999). These
findings are consistent with an essential role for rhoA- and
p160RhoK-dependent signaling in CoSMC development
from proepicardial cells in vitro and in vivo.
In previous work from this laboratory, we found that the
first proepicardial cells to express smooth muscle marker
proteins calponin, SMgA, and SM22a were those that had
begun to reorganize cytoskeletal actin from subcortical
bundles characteristic of epicardial cells to elongated stress
fibers (Landerholm et al., 1999). In the present study, we
found that PDGF-BB accelerated CoSMC differentiation in
parallel with actin reorganization and EMT. In fact, in an
ongoing screen for factors that can stimulate CoSMC dif-
ferentiation from proepicardial cells, we have been unable
to induce differentiation without EMT (unpublished obser-
vations). These findings suggest that the processes of SMC
differentiation and actin reorganization in isolated proepi-
cardial cells are somehow coupled and led us to examine
the molecular pathways involved. One such pathway may
be signaling via rhoA–GTPase. In addition to the well-
known ability of activating mutations of rhoA to promote
actin stress fiber formation, these mutants have also been
reported to stimulate SRF-dependent transcription of the
c-fos (Hill et al., 1995), skeletal a-actin (Wei et al., 2001),
and smooth muscle a-actin (Mack et al., 2001) promoters.
Hill et al. (1995) reported that activation of SRF by V14-
rhoA was independent of signaling through ERK, p38
MAPK, or JNK/SAPK. Likewise, we found that, although
SRF was required for PDGF-BB-mediated CoSMC differen-
tiation, inhibitors of MAPK kinase (MEK), p38 MAPK,
PI3K, or cytosolic phospholipase A2 had no inhibitory
effects. Moreover, a constitutively active form of p160RhoK
strongly stimulated transcription from a minimal c-fos
promoter consisting of two intact SRF binding sites but
lacking sites for ternary complex factor binding (Chihara et
al., 1997). Taken together, these findings suggest that rhoA
signaling, mediated at least in part by p160RhoK, can
orchestrate both actin reorganization and SRF-dependent
transcription.
Recently, a role for G-actin in control of SRF-dependent
transcription was proposed, based on evidence that deple-
genes in proepicardial cells. The results shown are representative of
at least three independent experiments for each marker. (B). Pro-
epicardial cells were treated for 60 h with PDGF-BB (20 ng/ml) in
the absence (A, C, E) and presence (B, D, F) of 10 mg/ml RKI.
Cultures were fixed and stained with phalloidin–Oregon green (A,
B), anti-calponin (C, D), or anti-SMgA (E, F) antibodies. Note that
treatment with RKI blocked EMT of proepicardial cells (A, B) and
abolished immunostaining for smooth muscle markers (D, F).FIG. 6. RKI blocks PDGF-BB-stimulated EMT and CoSMC differ-
entiation. (A) Proepicardial cells were exposed to PDGF-BB (20
ng/ml) for 60 h in the presence or absence of RKI (10 mg/ml) and
then analyzed by RT-PCR. Aliquots were removed from individual
PCR reaction tubes at 15, 20, 25, and 30 cycles to monitor linearity
of amplification. Only the results at the exponential phase of each
PCR reaction are shown. Note that treatment with RKI strongly
suppressed the expression of smooth muscle differentiation markerll rights reserved.
413Coronary Smooth Muscle Differentiationtion of G-actin pools activate, whereas actin overexpression
inhibits, SRF reporter gene expression in cultured fibro-
blasts (Sotiropoulos et al., 1999). Our studies do not rule out
such a role for G-actin pools in epicardial cells, although
they suggest an additional level of control by the cytoskel-
eton for CArG box-dependent transcription. We found that
p160RhoK was diffusely distributed throughout the resting
epicardial cell, perhaps in association with the intermediate
filament network as described by others (Sin et al., 1998).
Upon stimulation of EMT, p160RhoK was dramatically
redistributed to leading edge lamellipodia and to the
nucleus and perinuclear region. This redistribution of
p160RhoK was dependent on rhoA signaling. Whether
nuclear p160RhoK directly interacts with SRF is an impor-
tant question currently under study. However, it is likely
that redistribution of p160RhoK in proepicardial cells ex-
tends to other signaling molecules that are sequestered by
the cytoskeleton in inactive forms and then redistributed
upon cytoskeletal rearrangements to new locations and in
new combinations with other proteins during mesenchy-
mal transformation. If true, this may explain why we have
been unable to observe CoSMC differentiation without
actin reorganization in proepicardial cells. A similar role for
redistribution of cubitus interruptus (Ci) from microtubules
to the nucleus, mediated by a complex of costal-2 (Cos2)
FIG. 7. Inhibition of PDGF-BB-stimulated SRF expression by RKI
the absence or presence of RKI (10 mM) and then analyzed by (A
produced a complete loss of detectable expression of SRF mRNA o© 2001 Elsevier Science. Aand fused (Fu), is implicated in sonic hedgehog (Shh)-
mediated signaling (Murone et al., 1999).
We found that PDGF-BB stimulated EMT and CoSMC
differentiation from proepicardial cells, whereas PDGF-AA
or PDGF-AB had little or no effect. These results suggest an
important role for the PDGF b-receptor in conversion of
proepicardial cells to CoSMCs. The PDGF b-receptor me-
diates SMC chemotaxis (Grotendorst et al., 1982), stimu-
lates membrane ruffling, and promotes cytoskeletal rear-
rangements required for cell movement (Seigbahn et al.,
1990). It seems possible therefore that the primary effects of
PDGF b-receptor activation are to promote actin reorgani-
zation and stimulate cell movement. As a consequence,
SRF-dependent transcription is activated, perhaps in con-
cert with cell–substrate contacts that accompany EMT.
Indeed, synergistic activation of SRF-dependent transcrip-
tion of the skeletal a-actin promoter has been reported for
V14rhoA and b1-integrin-mediated signaling in myocardial
cells (Wei et al., 2001).
We observed that inhibition of p160RhoK activity abol-
ished SRF expression and prevented CoSMC differentiation
in proepicardial cells. Identification of the critical sub-
strates for p160RhoK that mediate SRF-dependent tran-
scriptional activation in proepicardial cells is an important
direction for future work. One possible downstream media-
epicardial cells were treated for 60 h with PDGF-BB (20 ng/ml) in
-PCR or (B) immunofluorescence. Note that treatment with RKI
tein in proepicardial cells.. Pro
) RT
r proll rights reserved.
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© 2001 Elsevier Science. Ator of p160RhoK signaling may be LIM-kinase (LIMK), given
that LIMK-1 was shown to be a potent activator of SRF-
dependent transcription, an activity that required the actin
polymerization-inducing activity of LIMK-1 (Maekawa et
al., 1999; Sotiropoulos et al., 1999). Other possible sub-
strates for p160RhoK are SRF itself or an SRF cofactor. SRF
is subject to extensive covalent posttranslational modifica-
tions including phosphorylation by casein kinase II, double-
stranded DNA-PK, pp90RSK, CaM kinases II and IV, and
MAPKAP kinase-2, which generally increase DNA binding
affinity of SRF for the SRE and enhance transcriptional
activation (Manak et al., 1990; Liu et al., 1993; Rivera et al.,
1993; Heidenreich et al., 1999).
Lineage analysis studies in chick–quail chimeric em-
bryos show that proepicardial cells give rise to CoSMCs,
adventitial fibroblasts, cardiac fibroblasts, and valve inter-
stitial cells in vivo (Gittenberger-de Groot et al., 1998;
Dettman et al., 1998; Perez-Pomares et al., 1998; Vrancken
Peeters et al., 1999). Explanted HH17 proepicardial cells,
under the conditions used here, appear to convert entirely
to CoSMCs. It is clear therefore that additional signals must
operate in the intact developing heart to restrict CoSMC
differentiation to those epicardial-derived cells that are in
close proximity to coronary endothelium. Indeed, we pre-
viously reported that, although epicardial cells themselves
do not express SRF, epicardial-derived mesenchymal cells
in the AV canal are strongly SRF-positive and yet they fail
to express CoSMC markers (Landerholm et al., 1999).
Therefore, critical CArG box elements in CoSMC marker
genes are either not accessible to SRF or are blocked by
inhibitory cofactors in AV canal mesenchymal cells. An
inhibitory function of this type has recently been proposed
for Wilms’ tumor-1 protein to prevent premature differen-
tiation of epicardial derivatives during heart development
(Carmona et al., 2001).
To test the role of p160RhoK in the more complex setting
of heart development in vivo, we constructed two types of
chick–quail chimeric embryos. In the first series, trans-
planted quail PEOs were grafted between the host chick
smooth muscle layers around subepicardial vessels in the AV
groove (arrows in upper panels, AV, 340) and penetrating coronary
arteries in the interventricular septum (arrows in lower panels,
3200). (B) Immunofluorescence for SMaA on heart sections from
control vs RKI-treated chimeras again revealed disrupted CoSMC
formation in RKI-treated chimeric hearts (arrows in B, right panels)
compared to control chimeras (arrows in B, left panels) (3100). (C)
Anti-quail cell nuclear marker staining showed that quail
proepicardial-derived cells were scattered throughout the subepi-
cardial space and myocardial wall, and were visibly clustered
around coronary arteries (arrowheads) in control chimera hearts (C,
left panels). In chick hearts that received RKI-treated quail PEOs,
quail cells were found limited to the subepicardial space (arrows)
with few, if any, detectable quail cells in the myocardial wall (C,
right panels) (3100). AV: atrial–ventricular groove; IV: interven-
tricular septum.FIG. 8. RKI disrupts coronary smooth muscle formation in vivo.
(A) Histology of chick hearts with a chimeric epicardium at
ED12.5: Chimeric chick hearts that received a large contribution of
RKI-treated quail proepicardial cells exhibited a lack of organizedll rights reserved.
415Coronary Smooth Muscle DifferentiationPEO and the heart tube. The host PEO was not removed so
that the epicardium that formed was a mixture of chick and
quail epicardial cells. The fate of RKI-treated quail epicar-
FIG. 9. Time course of epicardial-derived cells in myocardial wal
1 subepicardium compartment (hatched bars) vs the myocardial com
groove (see Materials and Methods) was determined by anti-quai
epicardium at (A) ED5.5, (B) ED7.5, and (C) ED12.5. Note that quai
control chimeric hearts (Ctl, open bars), but fail to accumulate in th
bars) (compare A, B, and C). To test whether a different method to
quail cells in ED5.5 chick hearts in which outgrowth of the host chi
In these chimeras, the epicardium is almost entirely derived from
D). Again, numerous quail epicardial-derived mesenchymal cells
However, the number of RKI-treated quail epicardial cells within
cence staining showing the fate of grafted quail epicardial-derived c
(F) quail PEOs using the egg shell membrane method (3100). Note
canal and myocardium of control (CTL) chimeras, whereas in chime
in the AV canal but almost entirely absent from the myocardium
AV 5 atrioventricular groove; LA 5 left atrium. Broken yellow lin© 2001 Elsevier Science. Adial cells was monitored by staining for a quail-specific
nuclear marker. This method allowed chick embryos to
survive past the point of lethality that is observed after total
himeric hearts. (A–C) The number of quail cells in the epicardium
tment (open bars) from the portion of the heart surrounding the AV
nuclear marker staining (QCPN) of chick hearts with chimeric
cardial cells move into and accumulate within the myocardium of
ocardium of hearts that received RKI-treated quail PEOs (RKI, open
uce chimeric hearts gives similar results, we examined the fate of
O was blocked by insertion of a piece of egg shell membrane (D–F).
rafted quail PEO (note the increase in scale of the ordinate in A vs
ound in the myocardium of control chimeras (D, Ctl open bar).
yocardium is greatly reduced (D, RKI open bar). Immunofluores-
ed) in chick hearts at ED5.5 after grafting control (E) or RKI-treated
numerous QCPN-positive quail cells (arrows) are found in the AV
ceiving RKI-treated quail PEOs, QCPN-positive cells are abundant
ws). Arrowheads mark the AV groove region. LV 5 left ventricle;
tlines the limits of the myocardial wall.l of c
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416 Lu et al.PEO ablation (Gittenberger-de Groot et al., 2000) so that
well-developed coronary artery walls could be formed. In
control experiments, we verified that freshly excised PEOs
treated with RKI overnight, washed thoroughly, and then
plated into RKI-free medium exhibited long-lasting inhibi-
tion of EMT (.80% inhibition at 5–7 days after plating). In
chimeric embryos that received a large contribution of
RKI-treated quail epicardial cells, we observed striking
coronary wall defects including a dramatic reduction in the
number of SMaA-positive CoSMCs surrounding subepicar-
dial and penetrating coronary vessels.
A time course analysis suggested that RKI-treated quail
cells participate normally in epicardium formation and
undergo EMT in the AV canal. However, they are defective
in migration into and/or survival within the myocardial
layer, resulting in a depletion of CoSMC precursors. To test
this conclusion by an alternative method, we constructed a
second series of chimeric embryos by preventing outgrowth
of the host PEO with a piece of egg shell membrane. This
results in an epicardial layer that is almost entirely derived
from the grafted quail PEO (Manner, 1999). Again we
observed that RKI-treated proepicardial cells formed an
epicardial layer and produced mesenchymal cells (EPDCs)
in the AV canal, but failed to populate the myocardial wall.
TUNEL assays suggested that increased rates of apoptosis of
EPDCs within the myocardium may explain the relative
absence of these cells in the ventricular wall.
Our results for EPDCs are very similar to those of Shibata
et al. (2000) for neointimal SMCs after acute vascular injury
in adult rats. In this model, SMCs migrate from the injured
media into the neointima, where they proliferate and pro-
duce large amounts of extracellullar matrix. Treatment
with RKI inhibits neointimal formation primarily by in-
creasing rates of intimal SMC apoptosis without affecting
cell proliferation or producing apoptosis in medial SMCs or
in regenerating endothelial cells. Thus the survival of SMCs
as they move into the new environment of the neointima
requires p160RhoK-dependent signaling. We suggest that a
similar requirement for compartment-specific survival fac-
tors may govern the distribution of EPDCs within the
developing heart. If true, this might explain, at least in part,
the failure of coronary vessel formation in FOG2-deficient
mice (Tevosian et al., 2000).
The multiple fates of EPDCs during cardiac development
(Gittenberger-de Groot et al., 1998) and the reciprocal
signaling pathways between these cells and cardiac myo-
cytes that are required for normal heart formation (Sucov et
al., 1994; Yang et al., 1995; Moore et al., 1999; Tevosian et
al., 2000) highlight the need for a better understanding of
the factors that control recruitment, survival, and differen-
tiation of epicardial-derived cells within different compart-
ments of the developing heart.
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